Almasry Pharmacy

Edemex Tablets

Short Description:
Edemex is a bumetanide-based loop diuretic injection used to treat edema associated with heart failure, liver disease, and kidney disorders including nephrotic syndrome. It promotes rapid removal of excess fluid and salts under strict medical supervision, helping relieve swelling and symptoms of fluid overload.

EGP 7

Out of Stock
delivery-iconDelivery to governorates within 3-4 working days
refund-iconEasy returns within 14 days
Specifications
SKUISG001212
BrandEdemexLink Icon
Categories
Medication & Treatments
Color
Luscious Blackberry
Shop by ConcernsEdemaLink Icon, Heart FailureLink Icon, Hepatic EdemaLink Icon, Nephrotic SyndromeLink Icon, Renal EdemaLink Icon
Gender
Unisex
Shop By GoalsManage Infectious DiarrheaLink Icon, Reduce EdemaLink Icon, Support Blood HealthLink Icon, Support Kidney FunctionLink Icon
Imported Or LocalLocal
Ingredient
Bumetanide
UPC
6221050030074
Product Form
Tablets
Specialty
Clinically Tested
Hospital Use
Potent Diuretic
Sub Categories
Diuretic
Warning
For intramuscular or intravenous use only under medical supervision
May cause electrolyte imbalance
Monitor blood pressure and kidney function
Not for self-diagnosis of serious conditions
About the product

Edemex Tablets

Description:

Edemex is a prescription loop diuretic medication containing bumetanide, used to treat fluid retention (edema) associated with congestive heart failure, liver disease, and kidney disorders including nephrotic syndrome. By increasing urine output and promoting the excretion of excess water and salts, Edemex helps relieve swelling in the legs, ankles, lungs, and other tissues, and supports better cardiovascular and renal function under medical supervision.


Indications:

  • Treatment of edema associated with congestive heart failure.
  • Treatment of edema due to hepatic disease (such as liver cirrhosis).
  • Treatment of edema associated with renal disease, including nephrotic syndrome.
  • Relief of symptoms related to fluid overload such as swelling of legs and ankles, abdominal distension, and shortness of breath caused by pulmonary congestion, as assessed by a physician.

Active Ingredients / Key Components:

  • Bumetanide – 0.5 mg per 2 ml ampoule (concentration: 0.25 mg/ml).

Dosage & Administration / How to Use:

  • Edemex (bumetanide) is administered by intramuscular (i.m.) or intravenous (i.v.) injection only by a healthcare professional.
  • The usual adult dose and frequency are determined individually by the physician based on the severity of edema, kidney function, and response to treatment. Typical initial doses may range from 0.5 mg to 1 mg, but exact dosing must follow the prescribing doctor’s instructions.
  • For i.v. use, the ampoule may be injected slowly as a direct i.v. injection or diluted in a suitable infusion solution as directed by hospital protocols.
  • For i.m. use, the injection is given deep into a large muscle; rotation of injection sites is recommended to minimize local irritation.
  • Patients should not self-inject this medication. It must be given in a clinical setting where blood pressure, urine output, and electrolytes can be monitored.
  • Food intake does not affect parenteral administration; however, patients should follow any fluid or salt restriction advised by their doctor.
  • Do not change the dose, frequency, or duration of therapy without consulting your healthcare provider.

Clinical Benefits:

  • Provides potent diuretic action to remove excess fluid from the body and reduce edema.
  • Helps relieve symptoms of fluid overload such as swelling, weight gain due to fluid, and shortness of breath related to pulmonary congestion.
  • Supports management of edema in patients with congestive heart failure, improving comfort and exercise tolerance when used as part of a comprehensive treatment plan.
  • Aids in controlling fluid retention in hepatic and renal diseases, including nephrotic syndrome, under specialist supervision.

Warnings & Contraindications:

  • Contraindicated in patients with known hypersensitivity to bumetanide, other sulfonamide-derived drugs, or any component of the formulation.
  • Contraindicated in patients with anuria (no urine production) or severe electrolyte depletion until corrected.
  • Use with extreme caution in patients with severe renal impairment, severe hepatic disease, or those at risk of electrolyte imbalance (e.g., low potassium, low sodium).
  • May cause significant drops in blood pressure; monitor blood pressure regularly, especially in elderly patients or those taking antihypertensive drugs.
  • Regular monitoring of serum electrolytes (sodium, potassium, chloride), kidney function, and fluid status is essential during therapy.
  • Consult your doctor before use if pregnant or planning pregnancy. Bumetanide should be used in pregnancy only if clearly needed and prescribed by a specialist.
  • Consult your doctor before use if breastfeeding; a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.
  • Use cautiously in patients with diabetes, gout, low blood pressure, or those taking other diuretics, cardiac glycosides (e.g., digoxin), antihypertensives, or nephrotoxic/ototoxic medicines (e.g., aminoglycoside antibiotics).
  • May impair the ability to drive or operate machinery if dizziness, lightheadedness, or fatigue occur.
  • Not intended to diagnose, treat, cure, or prevent any disease without a doctor’s prescription and supervision.
  • Keep out of reach of children.

Side Effects:
  • Common side effects may include increased urination, dizziness, headache, low blood pressure (hypotension), nausea, or muscle cramps due to electrolyte loss.
  • Electrolyte disturbances such as hypokalemia (low potassium), hyponatremia (low sodium), hypochloremia, and dehydration can occur and may be serious if not monitored and corrected.
  • Less common side effects may include rash, itching, photosensitivity reactions, or gastrointestinal discomfort.
  • Rare but serious side effects include severe dehydration, severe hypotension, kidney function deterioration, hearing disturbances (ototoxicity, especially with concomitant ototoxic drugs), or severe allergic reactions.
  • Seek immediate medical attention if you experience severe dizziness or fainting, confusion, extreme thirst, very dry mouth, irregular heartbeat, difficulty breathing, swelling of the face or tongue, or signs of severe allergic reaction.

Storage Instructions:

Store in a cool, dry place away from direct sunlight. Keep container tightly closed. Keep out of reach of children. Do not use after the expiry date printed on the pack. Do not freeze. Discard any unused portion of an opened ampoule according to local regulations.


Specifications:
  • Product form: solution for injection in ampoules.
  • Strength: 0.5 mg bumetanide per 2 ml ampoule (0.25 mg/ml).
  • Route of administration: intramuscular (i.m.) or intravenous (i.v.) by healthcare professionals only.
  • Pack size: 3 ampoules of 2 ml each.

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.

Product Reviews

Overall Rating
0

Based on 0 reviews

Warning iconYou can add a rating once you purchase the product through the My Orders page

Customer Reviews
No reviews yet
TelegramWhatsApp